Global Biopharmaceutical Company - Bristol Myers Squibb
Annual Report 2022 >
2022 was an important year for our company, with significant clinical and regulatory achievements that broadened our portfolio, advanced our pipeline and, importantly, delivered innovative new medicines to patients. To learn more, and to view important cautionary statements about forward-looking information, read our 2022 Annual Report.
2021 GLOBAL INCLUSION & DIVERSITY
Leading with our Value of Inclusion
Moving forward. Together.
Emmy award winner Sterling K. Brown explores what it means to live with cancer in a series of conversations with survivors from across the country.
We’re looking for people who want to change lives. Join us as we transform patients’ lives through science.
Learn more about how we strive to produce sustained strong performance and shareholder value.
Looking for answers?
Quick links to helpful resources.